Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2026

Conditions
Salivary Gland Cancer
Interventions
OTHER

Observation

Observational study, no intervention

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER